Go to the M D Anderson Home Page

Back to the PTSG Home Page



News and Progress
PTSG Top Web Picks
Pancreatic Cancer - Frequently Asked Questions
Diagnosis and Treatment
Clinical Studies
Who are the Pancreatic Tumor Study Group specialists?
How to refer a patient for evaluation
Pancreas Cancer Survivors
From Bench to Bedside: Basic Science Research


  


News and Progress
from August, 1999

Back to Current News Page

August 26 , 1999

Research/Education:

Dr. Douglas Evans and Dr James Abbruzzese have been appointed to the Scientific Advisory Board of the Lustgarten Foundation for Pancreatic Cancer Research. This foundation is a collaboration of medical and laboratory scientists pooling their resources to identify new strategies in pancreatic cancer treatment.

To see the newly-founded Lustgarten Foundation website, click the above logo or go to the PTSG Top Web Picks page.

August 12 , 1999

Clinical Trials: Multidisciplinary

The PTSG announces the openeing of a new protocol ID98-248, "Phase II Study of Gemcitabine-based Chemoradiation and TNP-470 for Patients with Locally-Advanced, Non-metastatic Adenocarcinoma of the Pancreas." This study is testing a new combination of standard chemoradiation developed at M D Anderson with an angiogenesis inhibitor. It is hoped that this combination will prevent liver metastases. For more information on this study, see the Category C section of our Clinical Trials page.

Education/Awareness:

An Olympic flag, autographed by 77 Gold Medal winners is up for auction at Acubid.com. Proceeds from the auction will benefit the Pancreatic Cancer Action Network. To see the flag and get more information on bidding, etc, go to http://www.acubid.com/item/docs/ViewItem.asp?Item=100124. (Be sure your browser is set to accept cookies.) For more information on PanCAN, click on the icon above or go to the PTSG's Top Web Picks page.